Prospective Follow-up of the Prevision Hip Stem With Comparison of Different Implant Variants
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAesculap AG
About this trial
The study design is confirmative for non-inferiority of the functional outcome of the implants and is intended to examine the safety and performance of the Prevision hip stem. The study is an observational post-market clinical follow-up study, and the study sites chose the stem variant depending on their own routine and indication.
Eligibility criteria
Qualifiers
Revision hip arthroplasty patients treated with a Prevision hip stem
Written patient informed consent
Patients are able to attend at follow-up examinations
Disqualifiers
Patients < 18 years at surgery
Pregnancy at implantation
Patients held in a custodial setting
Patients in a relationship of dependence on the sponsor, the clinic or the investigator
Trial design
Treatments tested in this trial
- Prevision Revision hip endoprosthesis stem implantation
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov